In breast cancer (MCF-7), it induces cell cycle arrest at the G2/M cell phase, increases ROS levels and inhibits the PI3K/AKT signaling pathway, thereby promoting apoptosis, and also accelerates apoptotic processes by down-regulating Bcl-2 and up-regulating Bax protein expression [1034]. This evidence concerns the gene BCL2 and breast carcinoma.